by Laya Kiani | Oct 22, 2025
Are you an early-stage startup founder looking for funding options without giving up equity? If so, non-dilutive funding may be the solution you need. It allows startups to advance research, build credibility and move closer to commercialization while maintaining full...
by CCRM Australia | Oct 1, 2025
Silvio Tiziani, MBA, GAICD, is the CEO of CCRM Australia, leading efforts to bridge the gap between research and industry in regenerative medicine. With extensive experience across academia, health, and industry, he has successfully developed strategic partnerships,...
by Lyla El-Fayomi | Jul 17, 2025
The volume of clinical updates I encounter every month is steadily but very noticeably growing month over month! There are lots to get through, so in this rapid-fire edition of RMNU🔬, you’ll find short summaries on all the biggest headlines of the summer’s first half....
by Kevin Robb | May 22, 2025
For the first time, mesenchymal stromal cells (MSCs) can be used in routine clinical practice under the nod of regulatory approval in the United States. The MSC product known as Ryoncil was made available to patients in March 2025 following a historic decision from...
by Laya Kiani | Mar 6, 2025
The biotechnology sector has always been a hub of innovation, consistently pushing the boundaries of scientific and technological advancements. However, transforming novel discoveries into viable market-ready solutions requires substantial financial backing. Among the...
Comments